ORTEXORTEX News
Tracking ASUR? Get live short interest, options flow, and signals on ORTEX.Sign up free →
AS
Trader NoteASUR

ASUR heads into Q1 earnings on a short-cover rally

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 3 min readdata as of 30 Apr 2026, 04:54

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Asure Software reports Q1 2026 results today — and the stock enters the print with a notable contradiction between price and positioning.

The share price has climbed 17% over the past month to $9.23, recovering sharply from its early-April lows. Yet short sellers have been walking away. Short interest fell nearly 9% over the past week and is down 28% over the past month, now running at 3.3% of free float. That combination — rising price, falling short interest — tells a cover-driven story. Shorts built into weakness, gave up into the rally, and the lending market followed suit.

The positioning picture supports the same read. Borrowing costs have halved from their early-April peak above 1.1%, settling near 0.52% — historically cheap territory for this name. Availability is loose, well above the tight threshold. There is no squeeze pressure visible in the lending pool. The ORTEX short score of ~50 is mid-range and has been drifting down from a recent high of 51.5 on April 20, reinforcing the picture of gradual short-side retreat rather than any escalating bearish conviction. Options tell a similar story: the put/call ratio is running at 0.053, slightly below its 20-day average, offering no sign of defensive hedging ahead of tonight's print.

The Street is cautiously constructive. All covering analysts carry Buy or Outperform ratings, and the mean price target of $13.33 implies roughly 44% upside to the current price. Barrington Research, which has been the most active voice on the name, reiterated Outperform with a $15 target as recently as April 24 — six days before today's results. Zacks upgraded to Strong Buy earlier this week. The bull case rests on continued revenue growth, 7% organic expansion, and the company's cloud-based HCM platform gaining traction with cross-sell. The bear case centres on margin erosion — adjusted gross margins fell from 73% to 70% following the Lathem acquisition — and on bookings volatility, with large enterprise deals creating lumpy comparisons. Non-GAAP EPS has also disappointed versus expectations on higher interest costs and tax rates. The EV/EBITDA multiple of 7.6x has compressed slightly over the past 30 days, consistent with the stock having run up while fundamental expectations stayed anchored. The company also unveiled AsureWorks this week, a done-for-you managed payroll and HR service, signalling an effort to expand its addressable market ahead of the earnings call.

On the ownership side, CEO Patrick Goepel added over 216,000 shares earlier in the year, a notable position-build that still stands as the most recent insider accumulation of size. More recent insider activity has run the other way: the President and CFO both made small sales at $8.34 on April 1. These were modest in absolute terms — under $40,000 combined — and likely reflect routine equity plan transactions rather than directional conviction. With 98 institutional holders and names like Private Capital Management (14% of shares) and Needham Investment Management (9%) among the top holders, the ownership base is concentrated in dedicated small-cap investors who tend to be long-term holders.

The most instructive recent parallel is the February 26 print, when ASUR reported Q4 2025 results. The stock jumped more than 23% the following day and extended that to 26% over the subsequent five sessions — Q4 revenue came in at $39.3 million against $30.8 million a year earlier, and the company swung to a net profit. The prior Q3 release, disclosed in late October, also produced a strong reaction: a 20% one-day move and 22% over five days. Two consecutive double-digit post-earnings rallies set a demanding baseline for tonight's Q1 release, and with the stock already 17% higher over the past month, some of the optimism may already be in the price.

What to watch tonight: whether Q1 organic revenue growth holds near the 7% level cited in prior guidance, whether bookings recover from the 41% year-on-year decline that spooked the Street after Q3, and how management frames the AsureWorks launch as either a margin headwind or a longer-term revenue opportunity.

Stocks in this article

See the live data behind this article on ORTEX.

Open ASUR on ORTEX →

How this article was generated

Generated
30 Apr 2026, 04:55
Data as of
30 Apr 2026, 04:54
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signals

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.